Gonadorelin

What is Gonadorelin?

Gonadorelin is a synthetic version of gonadotropin-releasing hormone (GnRH), the body's own signal for reproductive hormones. It has real regulatory history: the branded product Factrel was FDA-approved in the 1980s for diagnostic and therapeutic use. That product was later withdrawn for commercial reasons, and there is no FDA-approved gonadorelin product actively marketed in the US today, so current use runs through compounding pharmacies. It shows up most often now as an adjunct in testosterone therapy.

How Gonadorelin works

Gonadorelin binds GnRH receptors on the pituitary and prompts it to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which keep the testes or ovaries active. There is a crucial detail in how it is dosed: pulsatile, intermittent exposure stimulates the axis, but continuous exposure paradoxically shuts it down. That is why timing matters so much. In testosterone therapy, external testosterone suppresses the body's own LH and FSH signal, and pulsed gonadorelin is used to keep that signal, and testicular function, alive.

What the research shows

Gonadorelin's core pharmacology is well established: as a GnRH analog it has a long clinical history in diagnosing pituitary and gonadal function and in fertility medicine. Its popular modern use, preserving testicular size and fertility during testosterone replacement, is more of a practical, clinic-driven application than something backed by large dedicated trials. The GnRH mechanism it relies on is textbook and solid; the specific TRT-adjunct protocols are based on clinical practice more than on big outcome studies.

Dosage and how it is used

Gonadorelin has a very short half-life, on the order of minutes, which is why it is dosed frequently and in pulses. Common TRT-adjunct protocols reference roughly 50 to 100 mcg subcutaneously a few times per week, while diagnostic and pulsatile-therapy uses follow their own schedules. Because it is compounded rather than sold as a standardized approved product, specifics vary by the prescribing clinician.

→ How to reconstitute Gonadorelin: calculator, units to draw & storage

Side effects and safety

Gonadorelin is generally well tolerated, with the most common issues being injection-site reactions and occasional headache, flushing, or nausea. Its short half-life and pulsatile use mean it works with the body's own feedback system rather than overriding it, which is part of its appeal as a TRT adjunct. The honest framing: it has genuine prescribing precedent as a GnRH analog, but its current status is compounded rather than actively FDA-approved, and its TRT use is off-label.

• Research depth: extensive GnRH pharmacology; TRT-adjunct use is clinic-driven.
• Pulsatile dosing stimulates the axis; continuous exposure suppresses it.
• Formerly FDA-approved (Factrel), now compounded and used off-label. Verify status independently.

Frequently asked questions

References

• Gonadorelin (GnRH): pharmacology and clinical use literature. PubMed / U.S. National Library of Medicine.
• Gonadorelin prescribing and product information. DailyMed / U.S. National Library of Medicine.